{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:24:11Z","timestamp":1762507451998,"version":"3.37.3"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,7,4]],"date-time":"2018-07-04T00:00:00Z","timestamp":1530662400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13063-018-2545-3","type":"journal-article","created":{"date-parts":[[2018,7,4]],"date-time":"2018-07-04T04:29:30Z","timestamp":1530678570000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["The effect of perioperative intravenously administered iron isomaltoside 1000 (Monofer\u00ae) on transfusion requirements for patients undergoing complex valvular heart surgery: study protocol for a randomized controlled trial"],"prefix":"10.1186","volume":"19","author":[{"given":"Seung Hyun","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae-Kwang","family":"Shim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Soh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong Wook","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byung Chul","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6130-2342","authenticated-orcid":false,"given":"Sak","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young-Lan","family":"Kwak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,7,4]]},"reference":[{"issue":"2","key":"2545_CR1","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/0003-4975(93)91048-R","volume":"55","author":"J Butler","year":"1993","unstructured":"Butler J, Rocker GM, Westaby S. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg. 1993;55(2):552\u20139.","journal-title":"Ann Thorac Surg."},{"issue":"2","key":"2545_CR2","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/0003-4975(96)00324-4","volume":"62","author":"RJ Huyzen","year":"1996","unstructured":"Huyzen RJ, van Oeveren W, Wei F, Stellingwerf P, Boonstra PW, Gu YJ. In vitro effect of hemodilution on activated clotting time and high-dose thrombin time during cardiopulmonary bypass. Ann Thorac Surg. 1996;62(2):533\u20137.","journal-title":"Ann Thorac Surg."},{"issue":"5","key":"2545_CR3","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1378\/chest.119.5.1461","volume":"119","author":"SR Leal-Noval","year":"2001","unstructured":"Leal-Noval SR, Rincon-Ferrari MD, Garcia-Curiel A, et al. Transfusion of blood components and postoperative infection in patients undergoing cardiac surgery. Chest. 2001;119(5):1461\u20138.","journal-title":"Chest."},{"issue":"1","key":"2545_CR4","first-page":"139","volume":"19","author":"LS De Santo","year":"2010","unstructured":"De Santo LS, Romano G, Galdieri N, et al. RIFLE criteria for acute kidney injury in valvular surgery. J Heart Valve Dis. 2010;19(1):139\u201347. discussion 148","journal-title":"J Heart Valve Dis."},{"issue":"2","key":"2545_CR5","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/S0003-4975(02)04370-9","volume":"75","author":"J Bucerius","year":"2003","unstructured":"Bucerius J, Gummert JF, Borger MA, et al. Stroke after cardiac surgery: a risk factor analysis of 16,184 consecutive adult patients. Ann Thorac Surg. 2003;75(2):472\u20138.","journal-title":"Ann Thorac Surg."},{"issue":"5","key":"2545_CR6","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1016\/j.athoracsur.2006.05.045","volume":"82","author":"CG Koch","year":"2006","unstructured":"Koch CG, Li L, Van Wagoner DR, Duncan AI, Gillinov AM, Blackstone EH. Red cell transfusion is associated with an increased risk for postoperative atrial fibrillation. Ann Thorac Surg. 2006;82(5):1747\u201356.","journal-title":"Ann Thorac Surg."},{"issue":"2","key":"2545_CR7","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/S0272-6386(96)90546-6","volume":"27","author":"DS Silverberg","year":"1996","unstructured":"Silverberg DS, Iaina A, Peer G, et al. Intravenous iron supplementation for the treatment of the anemia of moderate to severe chronic renal failure patients not receiving dialysis. Am J Kidney Dis. 1996;27(2):234\u20138.","journal-title":"Am J Kidney Dis."},{"issue":"4","key":"2545_CR8","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1089\/152581600419161","volume":"9","author":"RG Rohling","year":"2000","unstructured":"Rohling RG, Zimmermann AP, Breymann C. Intravenous versus oral iron supplementation for preoperative stimulation of hemoglobin synthesis using recombinant human erythropoietin. J Hematother Stem Cell Res. 2000;9(4):497\u2013500.","journal-title":"J Hematother Stem Cell Res."},{"issue":"Suppl 2","key":"2545_CR9","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1093\/ndt\/13.suppl_2.9","volume":"13","author":"RM Schaefer","year":"1998","unstructured":"Schaefer RM, Schaefer L. Iron monitoring and supplementation: how do we achieve the best results? Nephrol Dial Transplant. 1998;13(Suppl 2):9\u201312.","journal-title":"Nephrol Dial Transplant."},{"key":"2545_CR10","doi-asserted-by":"publisher","first-page":"S61","DOI":"10.1046\/j.1523-1755.1999.055Suppl.69061.x","volume":"69","author":"IC Macdougall","year":"1999","unstructured":"Macdougall IC. Strategies for iron supplementation: oral versus intravenous. Kidney Int Suppl. 1999;69:S61\u20136.","journal-title":"Kidney Int Suppl."},{"issue":"4","key":"2545_CR11","first-page":"319","volume":"84","author":"J Berniere","year":"1998","unstructured":"Berniere J, Dehullu JP, Gall O, Murat I. Intravenous iron in the treatment of postoperative anemia in surgery of the spine in infants and adolescents. Rev Chir Orthop Reparatrice Appar Mot. 1998;84(4):319\u201322.","journal-title":"Rev Chir Orthop Reparatrice Appar Mot."},{"issue":"2","key":"2545_CR12","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.athoracsur.2013.03.015","volume":"96","author":"M Ranucci","year":"2013","unstructured":"Ranucci M, Baryshnikova E, Castelvecchio S, Pelissero G. Major bleeding, transfusions, and anemia: the deadly triad of cardiac surgery. Ann Thorac Surg. 2013;96(2):478\u201385.","journal-title":"Ann Thorac Surg."},{"issue":"2","key":"2545_CR13","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/ajh.23354","volume":"88","author":"DB Bregman","year":"2013","unstructured":"Bregman DB, Morris D, Koch TA, He A, Goodnough LT. Hepcidin levels predict nonresponsiveness to oral iron therapy in patients with iron deficiency anemia. Am J Hematol. 2013;88(2):97\u2013101.","journal-title":"Am J Hematol."},{"issue":"7","key":"2545_CR14","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1681\/ASN.2007050567","volume":"18","author":"BA Molitoris","year":"2007","unstructured":"Molitoris BA, Levin A, Warnock DG, et al. Improving outcomes from acute kidney injury. J Am Soc Nephrol. 2007;18(7):1992\u20134.","journal-title":"J Am Soc Nephrol."},{"issue":"1","key":"2545_CR15","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1097\/SLA.0000000000001646","volume":"264","author":"B Froessler","year":"2016","unstructured":"Froessler B, Palm P, Weber I, Hodyl NA, Singh R, Murphy EM. The important role for intravenous iron in perioperative patient blood management in major abdominal surgery: a randomized controlled trial. Ann Surg. 2016;264(1):41\u20136.","journal-title":"Ann Surg."},{"issue":"2","key":"2545_CR16","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/trf.12195","volume":"54","author":"M Munoz","year":"2014","unstructured":"Munoz M, Gomez-Ramirez S, Cuenca J, et al. Very-short-term perioperative intravenous iron administration and postoperative outcome in major orthopedic surgery: a pooled analysis of observational data from 2547 patients. Transfusion. 2014;54(2):289\u201399.","journal-title":"Transfusion."},{"issue":"1","key":"2545_CR17","doi-asserted-by":"publisher","first-page":"15","DOI":"10.4103\/0971-9784.38444","volume":"11","author":"BH Scott","year":"2008","unstructured":"Scott BH, Seifert FC, Grimson R. Blood transfusion is associated with increased resource utilisation, morbidity and mortality in cardiac surgery. Ann Card Anaesth. 2008;11(1):15\u20139.","journal-title":"Ann Card Anaesth."},{"issue":"5","key":"2545_CR18","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1016\/S0003-4975(99)00755-9","volume":"68","author":"H Kiyama","year":"1999","unstructured":"Kiyama H, Ohshima N, Imazeki T, Yamada T. Autologous blood donation with recombinant human erythropoietin in anemic patients. Ann Thorac Surg. 1999;68(5):1652\u20136.","journal-title":"Ann Thorac Surg."},{"issue":"2 Suppl 2","key":"2545_CR19","first-page":"69","volume":"33","author":"H Gombotz","year":"1996","unstructured":"Gombotz H. Subcutaneous epoetin alfa as an adjunct to autologous blood donation before elective coronary artery bypass graft surgery. Semin Hematol. 1996;33(2 Suppl 2):69\u201370. discussion 71-62","journal-title":"Semin Hematol."},{"issue":"5","key":"2545_CR20","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1097\/ALN.0b013e318232004b","volume":"115","author":"YC Yoo","year":"2011","unstructured":"Yoo YC, Shim JK, Kim JC, Jo YY, Lee JH, Kwak YL. Effect of single recombinant human erythropoietin injection on transfusion requirements in preoperatively anemic patients undergoing valvular heart surgery. Anesthesiology. 2011;115(5):929\u201337.","journal-title":"Anesthesiology."},{"issue":"3","key":"2545_CR21","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1111\/vox.12278","volume":"109","author":"PI Johansson","year":"2015","unstructured":"Johansson PI, Rasmussen AS, Thomsen LL. Intravenous iron isomaltoside 1000 (Monofer(R)) reduces postoperative anaemia in preoperatively non-anaemic patients undergoing elective or subacute coronary artery bypass graft, valve replacement or a combination thereof: a randomized double-blind placebo-controlled clinical trial (the PROTECT trial). Vox Sang. 2015;109(3):257\u201366.","journal-title":"Vox Sang."},{"issue":"6","key":"2545_CR22","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1093\/icvts\/ivs344","volume":"15","author":"P Garrido-Martin","year":"2012","unstructured":"Garrido-Martin P, Nassar-Mansur MI, de la Llana-Ducros R, et al. The effect of intravenous and oral iron administration on perioperative anaemia and transfusion requirements in patients undergoing elective cardiac surgery: a randomized clinical trial. Interact Cardiovasc Thorac Surg. 2012;15(6):1013\u20138.","journal-title":"Interact Cardiovasc Thorac Surg."}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-018-2545-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13063-018-2545-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-018-2545-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,7]],"date-time":"2024-07-07T22:52:16Z","timestamp":1720392736000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-018-2545-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,4]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["2545"],"URL":"https:\/\/doi.org\/10.1186\/s13063-018-2545-3","relation":{},"ISSN":["1745-6215"],"issn-type":[{"type":"electronic","value":"1745-6215"}],"subject":[],"published":{"date-parts":[[2018,7,4]]},"assertion":[{"value":"5 May 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The trial protocol and related documents were approved by the competent authorities and the Institutional Review Board (IRB) of the University of Yonsei (approval number: 4-2016-0502). The trial was conducted in accordance with Good Clinical Practice and the Declaration of Helsinki. Informed consent was obtained in writing prior to any trial-related activities.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"I (Seung Hyun Lee) give my consent for information about myself to be published inTrials. I understand that the information will be published without my name attached, but that full anonymity cannot be guaranteed. I understand that the text and any pictures or videos published in the article will be freely available on the Internet and may be seen by the general public. The pictures, videos and text may also appear on other websites or in print, may be translated into other languages or used for commercial purposes. I have been offered the opportunity to read the manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"350"}}